Your browser is no longer supported. Please, upgrade your browser.
Avantor, Inc.
Index- P/E106.57 EPS (ttm)0.29 Insider Own0.80% Shs Outstand581.10M Perf Week-2.53%
Market Cap17.63B Forward P/E21.82 EPS next Y1.40 Insider Trans-22.73% Shs Float495.86M Perf Month-3.94%
Income169.00M PEG4.39 EPS next Q0.30 Inst Own91.60% Short Float3.79% Perf Quarter2.49%
Sales6.66B P/S2.65 EPS this Y110.70% Inst Trans1.03% Short Ratio4.54 Perf Half Y20.09%
Book/sh3.10 P/B9.83 EPS next Y10.61% ROA1.70% Target Price36.50 Perf Year76.39%
Cash/sh0.30 P/C102.20 EPS next 5Y24.28% ROE10.30% 52W Range16.37 - 33.99 Perf YTD8.28%
Dividend- P/FCF23.84 EPS past 5Y- ROI6.30% 52W High-10.33% Beta-
Dividend %- Quick Ratio1.20 Sales past 5Y58.60% Gross Margin32.90% 52W Low86.19% ATR0.89
Employees12400 Current Ratio1.80 Sales Q/Q17.60% Oper. Margin6.90% RSI (14)42.70 Volatility2.52% 2.92%
OptionableYes Debt/Eq2.57 EPS Q/Q372.30% Profit Margin2.50% Rel Volume1.00 Prev Close31.22
ShortableYes LT Debt/Eq2.56 EarningsApr 28 AMC Payout267.90% Avg Volume4.14M Price30.48
Recom1.70 SMA20-5.49% SMA501.25% SMA20015.12% Volume4,137,458 Change-2.37%
Apr-29-21Upgrade Stifel Hold → Buy $40
Mar-03-21Initiated Barclays Overweight $33
Nov-10-20Initiated KeyBanc Capital Markets Overweight $33
Sep-14-20Initiated Morgan Stanley Overweight $24
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jan-08-20Initiated Wells Fargo Overweight $22
Jan-07-20Initiated Citigroup Buy $21
Nov-15-19Initiated Stifel Hold
Aug-02-19Initiated Cleveland Research Neutral
Jun-14-19Initiated Janney Buy $27
Jun-12-19Initiated Raymond James Outperform $20
Jun-11-19Initiated William Blair Outperform
Jun-11-19Initiated UBS Buy $21
Jun-11-19Initiated SunTrust Buy $22
Jun-11-19Initiated Robert W. Baird Outperform $20
Jun-11-19Initiated RBC Capital Mkts Outperform $22
Jun-11-19Initiated Piper Jaffray Neutral
Jun-11-19Initiated KeyBanc Capital Markets Sector Weight
Jun-11-19Initiated JP Morgan Overweight $20
Jun-11-19Initiated Jefferies Buy
May-04-21 02:00PM  
May-03-21 09:29AM  
Apr-29-21 08:23AM  
Apr-28-21 04:05PM  
Apr-27-21 04:05PM  
Apr-26-21 01:26PM  
Apr-22-21 05:17PM  
Apr-21-21 12:34PM  
Apr-14-21 05:46PM  
Apr-13-21 05:18PM  
Apr-12-21 09:12AM  
Apr-08-21 11:57AM  
Apr-07-21 04:07PM  
Mar-31-21 04:05PM  
Mar-23-21 10:49AM  
Mar-18-21 04:21PM  
Mar-15-21 01:27AM  
Feb-26-21 06:26PM  
Feb-23-21 04:56PM  
Feb-22-21 06:03PM  
Feb-10-21 08:37AM  
Feb-03-21 09:00PM  
Feb-02-21 08:37AM  
Jan-29-21 12:00PM  
Jan-28-21 12:10PM  
Jan-27-21 07:00AM  
Jan-21-21 04:05PM  
Jan-13-21 11:30PM  
Jan-11-21 04:05PM  
Dec-17-20 08:37AM  
Dec-16-20 08:42AM  
Dec-15-20 08:04AM  
Dec-14-20 08:37AM  
Dec-07-20 08:48AM  
Nov-26-20 11:51PM  
Nov-23-20 08:37AM  
Nov-19-20 08:37AM  
Nov-16-20 04:27AM  
Nov-11-20 08:37AM  
Nov-09-20 12:34PM  
Nov-05-20 10:07PM  
Nov-04-20 04:05PM  
Nov-03-20 09:41AM  
Nov-02-20 08:37AM  
Oct-30-20 04:05PM  
Oct-29-20 01:30AM  
Oct-28-20 03:00PM  
Oct-27-20 04:05PM  
Oct-23-20 08:01AM  
Oct-21-20 04:05PM  
Oct-08-20 08:37AM  
Oct-06-20 10:16AM  
Oct-02-20 09:05AM  
Sep-28-20 06:48AM  
Sep-22-20 09:05AM  
Sep-11-20 01:05PM  
Sep-01-20 08:05AM  
Aug-31-20 09:25AM  
Aug-24-20 08:49AM  
Aug-20-20 08:31AM  
Aug-19-20 04:14PM  
Aug-10-20 08:01AM  
Jul-30-20 09:38AM  
Jul-29-20 05:55PM  
Jul-28-20 09:23AM  
Jul-22-20 12:32PM  
Jul-21-20 04:05PM  
Jul-15-20 12:10PM  
Jul-12-20 12:33PM  
Jul-07-20 04:15PM  
Jul-01-20 04:05PM  
Jun-30-20 08:25AM  
Jun-23-20 08:25AM  
Jun-08-20 01:57AM  
May-29-20 01:13PM  
May-26-20 04:05PM  
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ohri DevashishEVP, IMEAApr 30Option Exercise23.2153,6491,245,193209,537May 04 05:06 PM
Ohri DevashishEVP, IMEAApr 30Sale32.5853,6491,747,884155,888May 04 05:06 PM
Miller JustinEVP & General CounselApr 12Option Exercise23.21100,0002,321,000218,679Apr 13 06:02 PM
Ohri DevashishEVP, IMEAApr 12Option Exercise1.60100,160160,256256,048Apr 13 06:03 PM
Ohri DevashishEVP, IMEAApr 12Sale32.37100,1603,242,179155,888Apr 13 06:03 PM
Bramwell JamesEVP, Strategic PartnersApr 12Sale32.002,50580,160118,136Apr 13 06:02 PM
Vanderhaegen FredericEVP, EuropeApr 12Sale31.8027,075860,997216,594Apr 13 06:03 PM
Miller JustinEVP & General CounselApr 12Sale33.17102,8953,412,916118,679Apr 13 06:02 PM
Vanderhaegen FredericEVP, EuropeMar 09Sale28.2110,000282,100243,669Mar 10 05:08 PM
Wondrasch MichaelEVP & CIOMar 02Sale28.713,03687,164145,438Mar 03 05:11 PM
Eck Steven WSVP & Chief Accounting OfficerFeb 24Option Exercise0.008,550028,532Feb 26 06:44 PM
Brophy GerardEVP, Biopharma ProductionFeb 24Sale27.933,05985,438172,384Feb 26 06:34 PM
Brophy GerardEVP, Biopharma ProductionFeb 22Option Exercise17.6719,769349,318195,212Feb 23 05:51 PM
Brophy GerardEVP, Biopharma ProductionFeb 22Sale28.6219,769565,789175,443Feb 23 05:51 PM
Wondrasch MichaelEVP & CIOFeb 05Option Exercise23.2040,000928,000181,543Feb 08 06:23 PM
Wondrasch MichaelEVP & CIOFeb 05Sale29.7749,4681,472,662141,543Feb 08 06:23 PM
Brophy GerardEVP, Biopharma ProductionJan 11Option Exercise23.20378,5808,783,056394,847Jan 13 05:41 PM
Bramwell JamesEVP, Strategic PartnersJan 11Sale30.002,50575,150116,430Jan 13 05:43 PM
Brophy GerardEVP, Biopharma ProductionJan 11Sale30.06378,58011,381,196178,515Jan 13 05:41 PM
Brophy GerardEVP, Biopharma ProductionJan 06Sale27.2411,509313,505178,515Jan 08 07:31 PM
Brophy GerardEVP, Biopharma ProductionJan 04Option Exercise18.4559,4181,096,262249,442Jan 06 09:06 PM
Brophy GerardEVP, Biopharma ProductionJan 04Sale27.8459,4181,654,197190,024Jan 06 09:06 PM
Bramwell JamesEVP, Strategic PartnersDec 21Sale27.1410,020271,943117,768Dec 23 05:10 PM
Shaw ChristiDirectorDec 11Sale26.6814,286381,15011,319Dec 15 07:16 PM
Stubblefield MichaelPresident and CEODec 07Option Exercise1.60210,369336,5901,945,717Dec 08 07:09 PM
Stubblefield MichaelPresident and CEODec 07Sale27.4598,4522,702,5071,847,265Dec 08 07:09 PM
Stubblefield MichaelPresident and CEODec 04Option Exercise1.60880,6011,408,9622,147,536Dec 08 07:09 PM
Stubblefield MichaelPresident and CEODec 04Sale27.08412,18811,162,0511,735,348Dec 08 07:09 PM
New Mountain Investments III, 10% OwnerNov 10Sale24.8136,016,093893,490,83728,000,000Nov 10 09:24 PM
Ohri DevashishEVP, IMEAOct 05Option Exercise1.60103,440165,504201,671Oct 07 08:23 PM
Ohri DevashishEVP, IMEAOct 05Sale23.42103,4402,422,343151,671Oct 07 08:23 PM
Ohri DevashishEVP, IMEASep 16Option Exercise1.6035,00056,000186,671Sep 17 04:39 PM
Ohri DevashishEVP, IMEASep 16Sale23.0235,000805,700151,671Sep 17 04:39 PM
Miller JustinEVP & General CounselSep 08Sale21.1722,887484,518113,507Sep 09 04:43 PM
Natauri JoDirectorAug 21Sale19.5115,397,005300,341,67843,483,708Aug 25 08:46 PM
GOLDMAN SACHS & CO. LLC10% OwnerAug 21Sale19.5115,397,005300,341,67843,483,708Aug 25 08:40 PM
New Mountain Investments III, 10% OwnerAug 21Sale19.5125,575,472498,887,94564,016,093Aug 25 05:08 PM
GUPTA RAJIVDirectorAug 19Option Exercise1.601,147,9701,836,7521,856,716Aug 19 02:06 PM
Ohri DevashishEVP, IMEAJul 30Option Exercise1.6035,00056,000186,671Aug 03 05:45 PM
Ohri DevashishEVP, IMEAJul 30Sale21.3735,000747,950151,671Aug 03 05:45 PM
Ohri DevashishEVP, IMEAMay 29Option Exercise1.6065,000104,000186,671Jun 02 05:50 PM
Ohri DevashishEVP, IMEAMay 29Sale18.8465,0001,224,550151,671Jun 02 05:50 PM
New Mountain Investments III, 10% OwnerMay 26Sale15.9020,886,424332,192,30889,591,565May 28 06:01 PM
Natauri JoDirectorMay 26Sale15.9013,726,411218,249,93558,881,710May 28 05:35 PM
Connolly ThomasDirectorMay 26Sale15.9013,726,411218,249,93558,881,710May 28 05:31 PM
GOLDMAN SACHS & CO. LLC10% OwnerMay 26Sale15.9013,726,411218,249,93558,881,710May 28 05:26 PM
Wondrasch MichaelEVP & CIOMay 22Sale17.8222,987409,628154,087May 27 04:26 PM
Brophy GerardEVP, Biopharma ProductionMay 20Sale17.3625,495442,593196,583May 22 04:22 PM